Medical News Feed
German Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | Nucleoside reverse transcriptase inhibitors (NRTIs). |
| Generic Name : | Stavudine |
| Drug description : | Capsules: 15 mg yellow/red capsules marked BMS 1964 and 15; 20 mg brown capsules marked BMS 1965 and 20; 30 mg light orange/ dark orange capsules marked BMS 1966 and 30; 40 mg dark orange capsules marked BMS 1967 and 40. Solution: powder for oral solution. |
| Presentation : | Capsules, stavudine 15 mg , 20 mg , 30 mg , 40 mg . Oral solution, stavudine 1mg/mL. |
| Indications : | Antiviral combination treatment of HIV-1 infected patients. |
| Adult Dosage : | Doses to be taken 1 hour before meals, or if not possible taken with a light meal. Under 60 kg, initially 30 mg twice daily; over daily. |
| Child Dosage : | Under 3 months, not recommended. Adolescents, children and infants over 3 months, under 30 kg, initially 1 mg/kg twice daily; over 30 kg, same as adult dose. |
| Contra Indications : | Hypersensitivity to stavudine or any of the excipients. Lactation. |
| Special Precautions : | Renal impairment, history of peripheral neuropathy (monitor carefully), pancreatitis, raised liver enzymes, hepatitis, liver dysfunction (dicontinue if liver disease worsens), lactic acidosis, lactose intolerance. Elderly. Pregnancy. |
| Interactions : | Zidovudine. Potential to interact with trimethoprim and other actively secreted drugs. |
| Adverse Reactions : | Peripheral neuropathy, pancreatitis, headache, chills/ fever, malaise, diarrhoea, constipation, dyspepsia, asthenia, anorexia, nausea/ vomiting, pneumonia, pain, myalgia, arthralgia, insomnia, depression, anxiety, flu syndrome, sweating, dizziness, allergic reaction, rash, pruritus, benign skin neoplasms, lymphadenopathy, and neoplasms. Raised ALT, AST levels, lactic acidosis. |
| Manufacturer : | Bristol-Myers Squibb |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org